Fluorometholone-induced cataract after photorefractive keratectomy.
The use of topical corticosteroids following photorefractive keratectomy (PRK) is widespread. The major complications of potent corticosteroids are glaucoma and cataract formation; in order to decrease these complications, 0.1% fluorometholone administration is usually preferred after PRK. We report here a case of lens opacification which was induced by 0.1% fluorometholone administration after PRK in a period of 4 months. To our knowledge, this is the first reported case of 0.1% fluorometholone-induced cataract after PRK.
Bilgihan
K
K
Department of Ophthalmology, University of Gazi, Ankara, Turkey.
Gürelik
G
G
Akata
F
F
Hasanreisoglu
B
B
D000287:Administration, Topical; D000328:Adult; D000893:Anti-Inflammatory Agents / Q000008:administration & dosage / Q000009:adverse effects*; D001251:Astigmatism / Q000601:surgery; D002386:Cataract / Q000139:chemically induced* / Q000473:pathology; D003315:Cornea / Q000601:surgery*; D005260:Female; D005469:Fluorometholone / Q000008:administration & dosage / Q000009:adverse effects*; D005500:Follow-Up Studies; D005938:Glucocorticoids; D006801:Humans; D054018:Lasers, Excimer; D007908:Lens, Crystalline / Q000187:drug effects* / Q000473:pathology; D009883:Ophthalmic Solutions; D018903:Photorefractive Keratectomy
D000893:Anti-Inflammatory Agents; D005938:Glucocorticoids; D009883:Ophthalmic Solutions; D005469:Fluorometholone